热门资讯> 正文

摩根大通暂停评级，Wave Life Sciences股价上涨

2025-08-16 00:43

Wave Life Sciences (NASDAQ:WVE) quickly hit highs of the day, rising 5%, after JPMorgan suspended its rating, price target, and estimates on the company.
Some investors may be speculating that JPMorgan suspended its rating because it's advising the company on some type of transaction.

More on Wave Life Sciences

Wave Life Sciences Ltd. (WVE) Q2 2025 Earnings Call Transcript
Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months
Wave Life Sciences: Speculative, But Promising
Wave Life Sciences is a new Buy at Canaccord Genuity on near-term catalysts
Wave Life Sciences signals key Q3 and Q4 data catalysts as INHBE and AATD programs advance

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。